AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Richard A. Gonzalez
CEORichard A. Gonzalez
Employees
50,000
Employees50,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
50,000
Employees50,000

ABBV Key Statistics

Market cap
315.37B
Market cap315.37B
Price-Earnings ratio
65.43
Price-Earnings ratio65.43
Dividend yield
3.37%
Dividend yield3.37%
Average volume
7.67M
Average volume7.67M
High today
$179.74
High today$179.74
Low today
$177.58
Low today$177.58
Open price
$179.01
Open price$179.01
Volume
8.57M
Volume8.57M
52 Week high
$182.89
52 Week high$182.89
52 Week low
$130.96
52 Week low$130.96

ABBV News

Yahoo Finance 6d
Why AbbVie Dipped More Than Broader Market Today - Yahoo Finance

In the latest trading session, AbbVie (ABBV) closed at $179.86, marking a -0.59% move from the previous day. The stock fell short of the S&P 500, which register...

Why AbbVie Dipped More Than Broader Market Today - Yahoo Finance

Analyst ratings

57%

of 30 ratings
Buy
56.7%
Hold
43.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.